Success Metrics

Clinical Success Rate

90.9%

Based on 20 completed trials

Completion Rate

91%(20/22)

Active Trials

0(0%)

Results Posted

50%(10 trials)

Terminated

2(9%)

Phase Distribution

Ph phase_2

Ph phase_4

Ph early_phase_1

35%

Ph phase_1

39%

Ph not_applicable

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution23 total trials

Early Phase 1First-in-human

8(34.8%)

Phase 1Safety & dosage

9(39.1%)

Phase 2Efficacy & side effects

2(8.7%)

Phase 4Post-market surveillance

2(8.7%)

N/ANon-phased studies

2(8.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.0%

20 of 23 finished

Non-Completion Rate

13.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(20)

Terminated(3)

Detailed Status

Completed20

Terminated2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 18 (34.8%)

Phase 19 (39.1%)

Phase 22 (8.7%)

Phase 42 (8.7%)

N/A2 (8.7%)

Trials by Status

terminated29%

withdrawn14%

completed2087%

Recent Activity

0 active trials

Showing 5 of 23

completedearly_phase_1

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more

NCT05019430Early Phase 1

Cocaine and Zolmitriptan

Completed

NCT05809453Phase 1

Intranasal Cocaine and Temperature Regulation During Exercise

Completed

NCT03954938Early Phase 1

Behavioral Effects of Drugs (Inpatient): 38

Terminated

NCT03937986Early Phase 1

Suvorexant and Cocaine

Completed

NCT02538744Phase 1

Complementary Combination Therapy for Cocaine Dependence

Completed

NCT02239913Phase 1

Topiramate-Phentermine Combinations for Cocaine Dependence

Completed

NCT02522325Phase 1

Reinforcing Effects of Cocaine During Phendimetrazine Maintenance

Completed

NCT03519022Early Phase 1

Behavioral Effects of Drugs: Inpatient (35)

Completed

NCT01906346Early Phase 1

Impact of a Non-Drug Choice on Cocaine Reinforcement

Completed

NCT02383043Early Phase 1

Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer

Completed

NCT01851473Phase 1

Interactions Between Intravenous Cocaine and Acetazolamide or Quinine

Completed

NCT02233647Early Phase 1

Phendimetrazine and Cocaine

Completed

NCT00000270Phase 4

Brain Imaging: Cocaine Effects & Medication Development - 5

Withdrawn

NCT01706952Phase 4

Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery

Completed

NCT00451230Not Applicable

Metabolic Effects of Cocaine

Completed

NCT00000290Phase 1

Stress Hormones and Human Cocaine Use - 7

Completed

NCT00000315Phase 1

Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1

Completed

NCT00000316Phase 1

Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2

Completed

NCT00000292Phase 1

Acute Withdrawal From Smoked Cocaine - 9

Completed

NCT02141620Early Phase 1

n-Acetylcysteine and Cocaine

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 23